Seasonal Flu and COVID-19 Vaccine Distribution and Supply

Subscribe to our RSS feed | For more information, see RSS feeds help page.

For up-to-date information pertaining to flu vaccine distribution and supply (ex: shortages and delays), please refer to the below bulleted information, with the most recent updates provided at the top.

Registration for the 2024/25 Vaccine Preventable Respiratory Illness Immunization Program

Health care providers are required to register in order to receive influenza and COVID-19 vaccines from provincial stock. For the 2024/25 season, immunization providers will again be able to place orders and receive deliveries for influenza and COVID-19 vaccines. Pneumococcal vaccines will also be available to order. Please note: To ensure the most up to date contact information for each location, last year’s registration information has been removed from our system.

While there will be no deadline to register, providers are strongly recommended to do so no later than August 16, 2024, to ensure receipt of all communications, allow for the creation of distribution groups, and for allocation planning.

It is recommended when you register to provide an email address to a shared mailbox (if available) to ensure surveys and communications are received by all staff involved.

Please note: a five digit Holding Point Code (Client ID) is required in order to complete the registration. If your location does not already have an account with the provincial vaccine warehouse, please fill out the following form: https://www.gov.mb.ca/health/publichealth/cdc/protocol/npaf.pdf


2024/25 Influenza and COVID-19 Program Requirements:

  1. Patients/clients will be immunized as per Manitoba's influenza and COVID-19 vaccine eligibility criteria as outlined:
    Influenza: https://www.gov.mb.ca/health/flu/index.html and
    COVID-19: https://www.gov.mb.ca/covid19/vaccine.html
  2. Client immunization history will be reviewed prior to administration of a vaccine via eChart or the Provincial Health Information Management System (PHIMS). This will determine whether minimum intervals are being maintained for COVID-19 vaccines and/or if influenza vaccines have already been administered in the current influenza season.
  3. Informed consent will be obtained verbally or in writing and as per the Informed Consent Guidelines for Immunization: www.gov.mb.ca/health/publichealth/cdc/protocol/consentguidelines.pdf
  4. All vaccines administered are expected to be reported to MHSLTC within two (2) business days of administration through the provider's reporting route (e.g. direct entry into PHIMS or billing processes)

    For clients with no PHIN: record and submit doses administered to persons without a PHIN via the appropriate inputting information available here: https://manitoba.ca/asset_library/en/covidvaccine/administration-reporting-form-no-phin.pdf
  5. All patient/client immunization records must include (at minimum), the patient/client name, birthdate and personal health identification number (PHIN), if registered with MHSLTC, location of administration, provider, date of administration, vaccine product and manufacturer, lot number, dose, site, route of administration, and any additional regulatory requirements.
  6. Designate a refrigerator to store vaccines (NO BAR FRIDGES) that is monitored with an appropriate temperature-monitoring device such as a continuous temperature monitor or minimum/maximum thermometer (household mercury-styled thermometers are not acceptable) with temperatures being checked and recorded twice daily.

    For vaccine-specific guidance on the storage and handling requirements refer to their Product Monographs.

    For all cold chain monitoring requirements and how to report cold chain excursions review the Cold Chain Protocol for Vaccines and Biologics are available at: https://www.gov.mb.ca/health/publichealth/cdc/coldchain.html
  7. Ensure an anaphylaxis response protocol/plan is in place prior to providing immunizations (e.g. initiating emergency response (911), epinephrine administration, CPR etc.) based on the Canadian Immunization Guide for Anaphylaxis and other Acute Reactions following Vaccination: www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-2-vaccine-safety/page-4-early-vaccine-reactions-including-anaphylaxis.html.

CLICK HERE TO REGISTER >



+ 2023/24 Influenza Season

September 12, 2023

Important Update: Pfizer COVID-19 Vaccine UNAVAILABLE for 1st Order Survey Delivery

In the initial order survey, there were two options for COVID-19 vaccines (Moderna 6m+ and Pfizer 12yrs+), anticipating that both would be available for distribution. However, Manitoba Health has recently received information indicating that Moderna will be the only product available in time for the first deliveries. It is anticipated that Pfizer will be available a couple of weeks later than Moderna.

We understand that some of you may have indicated a preference for the Pfizer vaccine option initially, which we regretfully will not be able to fulfill during the first deliveries.

To ensure a smooth and efficient vaccination program, we would like to offer you the opportunity to update your vaccine order to move any of the Pfizer doses you ordered over to Moderna. If you would like to make changes to your order please resubmit your order prior to the survey close date of September 19th at 11:30 p.m. Our team will promptly process your updated request. Please ensure that the resubmitted order contains all vaccines that you need, including the influenza and pneumococcal vaccines.

If we do not receive an updated order by the specified deadline, your Pfizer doses will be cancelled automatically and only the Moderna doses ordered will be shipped.

PLEASE NOTE: Moderna is expected to be approved by Health Canada for everyone 6 months and older. The Moderna product is stable in the refrigerator for up to 4 weeks. Both Pfizer and Moderna vaccines are safe and effective and there is no longer a preference for which mRNA COVID-19 vaccine should be used as an additional dose for previously immunized individuals in fall 2023.

Manitoba Health has prioritized the procurement of the Moderna vaccine due to ease of administration (i.e., one formulation for all age groups) and given that there is no preferential recommendation for either mRNA vaccine product. Based on this information, please plan to receive primarily Moderna vaccine throughout the respiratory illness season.

We apologize for any inconvenience this change may cause and appreciate your understanding and flexibility as we adapt to the evolving vaccine supply situation. Our primary goal is to provide essential protection to our community against influenza and COVID-19, and your support in this endeavor is invaluable.

Should you have any questions or require further assistance in updating your vaccine order, please do not hesitate to reach out to our dedicated support team at vaccines@gov.mb.ca




August 10, 2023

As previously communicated, the Seasonal Influenza and COVID-19 Immunization Programs are transitioning into a single program. The ordering and distribution model has been revised to reflect that merge and further communications and instructions will follow shortly.

Please find below a summary of the changes regarding the 2023-24 Manitoba’s Influenza & COVID-19 Immunization Program:

Products

- Flu and pneumococcal vaccine products have not changed since last year.

- Pfizer, Moderna and Novavax are the anticipated manufacturers that will have products with updated formulations available. These new formulations and their age indications are still pending Health Canada approval.

- Moderna and Pfizer's products are expected to have limited stability once in the fridge. The provincial warehouse will be shipping the product with the influenza doses in refrigerated temperatures. Once received:

  • Moderna is only good in the fridge for 30 days (unopened)
  • Pfizer is only good for 12 weeks in the fridge (unopened)
  • More details will be made available and shared on product specifications once approved by Health Canada

- At this time, it is unknown when jurisdictions will receive their allotments of COVID-19 vaccines as approval from Health Canada is pending. It is anticipated that product will be available for shipping with the influenza vaccines in late September.

- Novavax is the only non-mRNA COVID-19 vaccine that will be available this fall.

Note: Manitoba Health is not implementing a publicly-funded RSV vaccine program for older adults this year.

Registration for Manitoba’s Influenza & COVID-19 Immunization Program opened on July 13, 2023. Every location that plans to participate in Manitoba’s Influenza and COVID-19 Immunization Program must register in order to participate in the program, including those who registered for the previous seasons. While providers can register at any time during the season, it is strongly recommended that you complete your registration by submitting this online form by August 15, 2023, to ensure that you will be included in the communications list and distribution group prior to the beginning of the season.

Orders and Clinics

It is anticipated that online ordering surveys will go out every two weeks (the exact timing of the first order survey is still to be determined) and will be based on two distribution groups. Personal Care Homes, Hospitals, and First Nations Communities will be included within the first distribution group. Locations are encouraged to start immunizing as soon as they receive flu vaccines.

Personal Care Homes should strive to complete the influenza immunizations for all eligible residents by October 31, 2023. COVID-19 vaccine administration is expected to be based on time since last infection or dose.

Public health offices should schedule their clinics starting the week of October 23, 2023 to ensure adequate time for vaccines to be delivered.




July 13, 2023

RE: 2023/24 COVID-19 and Influenza Immunization Program Registration is Now Open

Manitoba Health is combining the COVID-19 and seasonal influenza vaccine ordering processes for the 2023/24 season. Registration is mandatory for all health care providers, including those who had previously registered for the influenza and/or COVID-19 programs.

Please complete the registration form HERE.

IMPORTANT: During registration, we ask that you provide an estimate of how many total doses your location anticipates ordering this fall, this is not an official order and no doses will be shipped to your location using these estimates. Please ensure that you monitor your email for order surveys in the fall.

It is recommended that all healthcare providers complete the online registration form by August 15, 2023, to ensure receipt of all communications, allow for the creation of distribution groups, and for allocation planning.

COVID-19 and Influenza Distribution Overview

  • The exact timing of the first order survey is not known at this time.
  • Influenza and COVID-19 supply is anticipated to start arriving sometime in September with the potential to begin shipping by the end of September.
  • Similar to last year, the creation of two distribution groups is being considered.
  • Manitoba will continue to have Personal Care Homes, Hospitals, and First Nations Communities included within the first distribution group and those locations will be encouraged to order and administer their vaccines as soon as possible in the fall respiratory season (following provincial program guidelines).

Updates to Current COVID-19 Vaccine Ordering

Please be advised that the last order survey for COVID-19 vaccines will be sent on July 21st for delivery the week of July 31st. There will be no more COVID-19 vaccine orders processed until the new combined ordering and delivery model comes into effect for the fall immunization program.

If you have any questions, please contact the Communicable Disease Control Unit at 204-788-6737 or by email at vaccines@gov.mb.ca.



June 21, 2023

For the 2023/24 season, the ordering of influenza and COVID-19 vaccines will be combined into one process. This way, immunization providers will be able to place orders and receive deliveries of both influenza and COVID-19 vaccines at the same time.

In order to participate in the 2023/24 influenza and COVID-19 immunization program, all health care providers will need to register. Those who currently order COVID-19 vaccines through the survey process will continue to do so at this time, but will still be required to register for the 2023/24 influenza and COVID-19 immunization program. Communication will be sent in the coming weeks to advise when the current COVID-19 vaccine ordering will cease to allow for a transition to the new season.

While there will be no deadline to register, it is strongly recommended that providers do so no later than August 15, 2023, to ensure receipt of all communications, allow for the creation of distribution groups, and allocation planning. The new program is expected to streamline the process and make it more efficient for all providers.

Please be advised that the provision of administration supplies for COVID-19 vaccines will be discontinued effective September 1, 2023. As the inventory of supplies runs out it will be removed from the current COVID-19 ordering surveys. Providers are expected to source their administration supplies as they did prior to the COVID-19 pandemic.

More information regarding the new influenza and COVID-19 vaccine ordering and delivery program, including a link to the new registration form, a timeline for the first survey, order frequency, and other information will be forthcoming in the coming weeks.

*NOTE: The remodelled ordering and distribution process applies to the seasonal flu vaccine (standard and high dose), the pneumococcal polysaccharide (Pneu-P-23), and COVID-19 vaccines.



June 5, 2023

SPRING CLEANING – VACCINE RETURNS

All health care providers are kindly asked to do a scan of their vaccine fridges to locate all expired publicly funded vaccines and arrange with the provincial distribution warehouse (MDA) to have them returned. Manitoba may receive credit for expired vaccines that have been returned.

This is especially important for influenza vaccines. All expired and unusable doses should be returned to MDA within two months of expiry.

Please refer to the latest Health Care Provider letter for more information:
https://www.gov.mb.ca/health/flu/docs/spring-cleaning-letter.pdf


+ 2022/23 Influenza Season
+ 2021/22 Influenza Season
+ 2020/21 Influenza Season
+ 2019/20 Influenza Season
+ 2018/19 Influenza Season
+ 2017/18 Influenza Season
+ 2016/17 Influenza Season
+ 2015/16 Influenza Season